PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25622N0368FDA approved automated BLOOD BANK analyzer — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

256-Network Contract Office 16 (36C256)
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Sep 30, 2026
PoP end
$476K
Obligated
$580K
Potential
334516
NAICS
6640
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract number36C25622N0368
Also listed as36C256-22-N-0368
Also listed asV797D60637-36C25622N0368
Agency256-Network Contract Office 16 (36C256)
Awarding office256-Network Contract Office 16 (36C256)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDVV797D60637
Place of performanceRARITAN NJ
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJan 1, 2022
PoP end (current)Sep 30, 2026
Obligated$476K
Current value$576K
Potential value$580K

FDA APPROVED AUTOMATED BLOOD BANK ANALYZER AT CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM (CAVHS) is a federal award for 256-Network Contract Office 16 (36C256) held by Ortho-Clinical Diagnostics, Inc. Estimated value $580K ($476K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: RARITAN NJ.

FDA APPROVED AUTOMATED BLOOD BANK ANALYZER AT CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM (CAVHS)

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25622N0368?

36C25622N0368 (FDA approved automated BLOOD BANK analyzer) is a 256-Network Contract Office 16 (36C256) award with a potential value of $580K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C256-22-N-0368?

36C256-22-N-0368 is the dashed form of PIID 36C25622N0368 (FDA approved automated BLOOD BANK analyzer), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25622N0368?

256-Network Contract Office 16 (36C256) awarded 36C25622N0368 to Ortho-Clinical Diagnostics, Inc (potential $580K).

Who is the incumbent on 36C25622N0368?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics, Inc’s 36C25622N0368 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25622N0368